Common risk factors for heart failure and cancer

Cardiovasc Res. 2019 Apr 15;115(5):844-853. doi: 10.1093/cvr/cvz035.

Abstract

Cardiovascular (CV) disease and cancer are the leading causes of death.1,2 Over the last decades, it has been appreciated that both CV disease and cancer are more common in individuals in whom risk factors for disease development accumulate, and preventative measures have been extremely important in driving down the incidence of disease.3-6 In general, the field of epidemiology, risk reduction, and preventative trials is divided into health care professionals who have an interest in either CV disease or cancer. As a result, the medical literature and medical practice has largely focused on the one disease, or the other. However, human individuals do not behave according to this dogma. Emerging data clearly suggest that identical risk factors may lead to CV disease in the one individual, but may cause cancer in another, or even both diseases in the same individual. This overlap exists between risk factors that are historically classified as 'CV risk factors' as these factors do equally strong predict cancer development. Therefore, we propose that a holistic approach might better estimate actual risks for CV disease and cancer. In this review, we summarize current insights in common behavioural risk factors for heart failure, being the most progressed and lethal form of CV disease, and cancer.

Keywords: Biomarkers; Cardio-oncology; Cardiovascular risk factors; Heart failure; Hypertension; Inflammation; Lipids; Risk factors.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Antineoplastic Agents / adverse effects
  • Cardiotoxicity
  • Cardiovascular Agents / adverse effects
  • Heart Failure / diagnosis
  • Heart Failure / drug therapy
  • Heart Failure / epidemiology*
  • Heart Failure / physiopathology
  • Humans
  • Neoplasms / diagnosis
  • Neoplasms / drug therapy
  • Neoplasms / epidemiology*
  • Neoplasms / physiopathology
  • Prognosis
  • Risk Assessment
  • Risk Factors

Substances

  • Antineoplastic Agents
  • Cardiovascular Agents